Changsheng Ma Selected Research

Lipids

1/2022	Disparities in Secondary Prevention between Stroke and Coronary Heart Disease in China: Cross-Sectional Community-Based Study, 2014-2016.
1/2021	Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case-control study based on the China Atrial Fibrillation Registry.
10/2018	Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model.
1/2016	Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study.
10/2013	Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changsheng Ma Research Topics

Disease

69	Atrial Fibrillation 05/2024 - 12/2006
14	Heart Failure 05/2024 - 01/2008
14	Stroke (Strokes) 04/2024 - 12/2015
12	Hemorrhage 12/2023 - 01/2018
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2013
11	Neoplasms (Cancer) 05/2024 - 01/2014
9	Thrombosis (Thrombus) 02/2024 - 01/2014
9	Myocardial Infarction 02/2024 - 01/2015
9	Tachycardia (Tachyarrhythmias) 01/2023 - 08/2014
8	Acute Coronary Syndrome 11/2022 - 09/2015
7	ST Elevation Myocardial Infarction 02/2024 - 06/2015
5	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 02/2011
5	Hypertension (High Blood Pressure) 04/2024 - 10/2013
4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2011
4	Inflammation (Inflammations) 12/2022 - 12/2007
4	Atrial Flutter (Flutter, Atrial) 01/2022 - 07/2015
4	Cardiac Arrhythmias (Arrythmia) 01/2019 - 01/2011
3	Essential Hypertension 04/2024 - 10/2015
3	Embolism (Embolus) 12/2023 - 01/2021
3	Transient Ischemic Attack 10/2023 - 01/2021
3	Anemia 01/2022 - 01/2020
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2012
3	Esophageal Squamous Cell Carcinoma 01/2022 - 12/2015
3	Diabetes Mellitus 01/2021 - 08/2012
3	Cardiac Tamponade 01/2020 - 07/2019
3	AIDS-Related Complex (ARC) 01/2014 - 01/2012
2	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2020
2	Hypercholesterolemia 12/2023 - 01/2020
2	Pulmonary Embolism 04/2023 - 04/2015
2	Ischemic Stroke 01/2023 - 01/2021
2	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 01/2023 - 12/2017
2	Esophageal Neoplasms (Esophageal Cancer) 12/2022 - 01/2022
2	Carcinogenesis 10/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 11/2017
2	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2022 - 10/2012
2	Hypotension (Low Blood Pressure) 01/2022 - 03/2013
2	Nasopharyngeal Carcinoma 11/2021 - 10/2012
2	Neoplasm Metastasis (Metastasis) 07/2020 - 01/2011
2	Hepatocellular Carcinoma (Hepatoma) 02/2020 - 01/2017
2	Chest Pain (Chest Pains) 01/2020 - 02/2011
2	Fibrosis (Cirrhosis) 01/2019 - 01/2008
2	Tinnitus 12/2007 - 07/2005
1	Pericarditis 05/2024
1	Cardiotoxicity 05/2024

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 01/2024 - 12/2015
6	omega-Chloroacetophenone (Mace)IBA 01/2023 - 06/2015
5	Vitamin K FDA Link 01/2024 - 11/2014
5	oxidized low density lipoproteinIBA 12/2023 - 01/2019
5	LDL CholesterolIBA 12/2023 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2011
5	LipidsIBA 01/2022 - 10/2013
4	Sodium-Glucose Transport ProteinsIBA 12/2023 - 01/2022
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 11/2013
4	Dabigatran FDA Link 08/2023 - 10/2019
4	Warfarin (Coumadin)FDA LinkGeneric 04/2023 - 04/2015
4	RivaroxabanIBA 01/2022 - 11/2014
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2022
3	Anti-Arrhythmia AgentsIBA 01/2023 - 01/2017
3	CreatinineIBA 01/2023 - 11/2014
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 08/2019
3	CholesterolIBA 01/2022 - 11/2013
2	Ezetimibe (Zetia)FDA Link 12/2023 - 01/2020
2	Rosuvastatin Calcium (Crestor)FDA Link 12/2023 - 08/2019
2	TicagrelorIBA 11/2022 - 01/2021
2	Clopidogrel (Plavix)FDA Link 11/2022 - 01/2021
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 11/2020
2	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2021
2	HDL CholesterolIBA 10/2021 - 01/2021
2	Ethanol (Ethyl Alcohol)IBA 05/2021 - 01/2021
2	MetalsIBA 01/2021 - 01/2014
2	Valsartan (Vals)FDA Link 08/2020 - 02/2015
2	Angiotensin Receptor AntagonistsIBA 08/2020 - 06/2009
2	Propafenone (Rythmol)FDA LinkGeneric 01/2019 - 03/2013
2	AngiotensinogenIBA 01/2016 - 08/2015
2	AlbuminsIBA 01/2016 - 01/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 08/2014
2	Blood Glucose (Blood Sugar)IBA 01/2016 - 10/2013
2	CollagenIBA 01/2008 - 03/2002
2	SalicylatesIBA 12/2007 - 07/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	Colchicine FDA LinkGeneric 05/2024
1	Dexrazoxane (Zinecard)FDA LinkGeneric 05/2024
1	ReninIBA 04/2024
1	TabletsIBA 04/2024

Therapy/Procedure

37	Catheter Ablation 04/2024 - 06/2007
24	Therapeutics 12/2023 - 12/2006
12	Radiotherapy 01/2022 - 01/2011
10	Radiofrequency Ablation 04/2024 - 08/2014
10	Percutaneous Coronary Intervention 02/2024 - 08/2012
7	Catheters 10/2023 - 01/2008
6	Stents 02/2024 - 01/2014
5	Punctures 01/2022 - 06/2007
4	Chemoradiotherapy 01/2024 - 11/2017
4	Secondary Prevention 01/2022 - 01/2016
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 01/2011
2	Aftercare (After-Treatment) 10/2023 - 01/2017
2	Septal Occluder Device 01/2022 - 10/2012
2	Ligation 01/2016 - 01/2015